Search

everythinglearnresearchcommunity

for

Search:↓

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

BMPR1a-ECD reduces wrinkles much more effectively than retinoic acid.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Quercetin effectively treated and prevented hair loss in mice.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Stopping S100A3 activity slows down hair growth in mice.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

A specific type of immune cells, called CD301b-expressing macrophages, are crucial for skin repair processes.

Cedrol promotes hair growth better than baricitinib by regulating immune cells.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Reducing neutrophils or inhibiting NETs improves wound healing in sickle cell disease.

Corni Fructus extract may help manage benign prostatic hyperplasia by reducing prostate cell growth and inflammation.

Lack of KSR1 stops certain skin tumors in mice.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

The mTurq2-Col4a1 mouse model shows how the basement membrane develops in live mammals.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

FOXN1 gene variants cause low T cells and immune issues from birth.

The combination therapy significantly improved Riehl’s melanosis in patients without serious side effects.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

Lack of Crif1 in hair follicle stem cells slows down hair growth in mice.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.